What is the appropriate meropenem dose for an adult with an eGFR of 30 mL/min?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: March 3, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the rationale for using meropenem and amoxicillin together?

How should meropenem be dosed in an adult patient based on creatinine clearance levels, intermittent hemodialysis, continuous renal replacement therapy, and augmented renal clearance?

In an adult postoperative intensive care unit patient after exploratory laparotomy who is being treated for severe sepsis with meropenem, teicoplanin, polymyxin B, metronidazole, and ofloxacin and has hypernatremia and severe hypokalemia, what is the appropriate venous thrombo‑embolism prophylaxis strategy?

How should I manage an adult postoperative ICU patient after exploratory laparotomy with severe sepsis on meropenem, teicoplanin, polymyxin B, metronidazole and ofloxacin who now has hypernatremia, severe hypokalemia and acute hepatic dysfunction (bilirubin 8.43 mg/dL, AST 320 U/L, ALT 183 U/L, elevated INR)?

What is the best management approach for a patient with a cracked nephrostomy tube, Klebsiella urinary tract infection (UTI), and impaired renal function, who is currently undergoing chemotherapy for bladder cancer?

What are the indications for endoscopy?

What is the appropriate management of upper airway cough syndrome?

What explains a mildly low serum creatinine with normal BUN and a modestly elevated BUN‑to‑creatinine ratio, and what is the appropriate clinical approach?

Can a copper intrauterine device be exchanged for a levonorgestrel intrauterine system?

Please develop a SOAP note for a 58‑year‑old male with hypertension, hyperlipidemia, and a 20‑pack‑year smoking history who had an exercise stress test showing significant ST‑segment depression in the inferior leads consistent with inducible myocardial ischemia, and explain the meaning of this cardiac diagnostic and its impact on his treatment plan.

What are the recommended therapeutic strategies for metabolic dysfunction-associated steatotic liver disease (MASLD) based on the predominant pathogenic driver: adipose‑driven disease, primary hepatic insulin resistance, or a PNPLA3 genetic predisposition?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.